Date: Tuesday, December 5, 2023
Time: 8:30 AM – 12:30 PM ET
Location:Leavitt Partners, LLC, 601 New Jersey Ave NW, Suite 350, Washington, DC
The Innovation and Value Initiative, Alliance for Aging Research, Leavitt Partners, LLC, and the National Pharmaceutical Council are hosting a public event focused on health equity, patient engagement, and related methodological and evidence issues in CMS’ implementation of the Drug Price Negotiation Program (DPNP) as mandated by the Inflation Reduction Act (IRA).
The half-day event aims to bring together a range of perspectives, including practical on-the-ground experience and broader policy and scientific expertise, in three panel sessions. The objective is to identify critical steps that CMS, policymakers, and others could take to address equity in implementing the IRA drug price negotiations.